Concepedia

Joshua R. Friedman

JR

Statistics

Publications

50

Citations

9.5K

H-Index

36

Active since

1985

Affiliations

Janssen (United States)(Current)

Children's Hospital of Philadelphia

University of Pennsylvania

Icahn School of Medicine at Mount Sinai

Sema4 (United States)

Joshua R. Friedman is an author at Janssen (United States) specializing in life sciences, inflammatory bowel disease, and inflammation.

ORCID

Publications per year

1985–2023

50

Publications

50

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Brian G. Feagan, William J. Sandborn, Christopher Gasink et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

, , +17

Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy

J.P. Martin, Christie Chang, Gilles Boschetti et al. · Cell · 2019 · 898 citations · Full text

, , +17

Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria

Gregory F. Sonnenberg, Laurel A. Monticelli, Theresa Alenghat et al. · Science · 2012 · 721 citations

, , +17

KAP-1, a novel corepressor for the highly conserved KRAB repression domain.

Joshua R. Friedman, William J. Fredericks, D. E. Jensen et al. · Genes & Development · 1996 · 675 citations · Full text

, , +16

Krüppel-associated boxes are potent transcriptional repression domains.

Judith Margolin, Joshua R. Friedman, Wolfram Meyer et al. · Proceedings of the National Academy of Sciences · 1994 · 627 citations · Full text

, , +15

1–5 of 50